Detalhe da pesquisa
1.
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma.
N Engl J Med
; 2024 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38828984
2.
Risk of radiation necrosis after stereotactic radiosurgery for melanoma brain metastasis by anatomical location.
Strahlenther Onkol
; 197(12): 1104-1112, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34114045
3.
Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial.
Lancet Oncol
; 20(7): 961-971, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31171444
4.
Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapies.
Eur J Cancer
; 153: 8-15, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34126335
5.
Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti-PD-1 antibodies.
Pigment Cell Melanoma Res
; 32(4): 553-563, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30767428
6.
Germline BAP1-positive patients: the dilemmas of cancer surveillance and a proposed interdisciplinary consensus monitoring strategy.
Eur J Cancer
; 92: 48-53, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29413689
7.
Radiological manifestations of immune-related adverse effects observed in patients with melanoma undergoing immunotherapy.
J Med Imaging Radiat Oncol
; 61(6): 759-766, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29024572
8.
Recurrent bowel obstruction: unusual presentation of pembrolizumab-induced pancreatitis in annular pancreas.
Eur J Cancer
; 82: 167-170, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28689094